You are here

Article info

Article menu

Download PDFPDF

Commentary
It’s TIME for a biomarker-driven approach to cancer immunotherapy

Authors

  • Leisha A. Emens Department of OncologyJohns Hopkins University School of Medicine The Kimmel Cancer Center at Johns Hopkins, Bunting-Blaustein Cancer Research Building 1, 1650 Orleans Street, Room 409 21231-1000 Baltimore MD USA PubMed articlesGoogle scholar articles
  1. ↵a (410) 502-7051 emensle{at}jhmi.edu

Citation

Emens LA
It’s TIME for a biomarker-driven approach to cancer immunotherapy
Journal for ImmunoTherapy of Cancer 2016;4:43. doi: 10.1186/s40425-016-0147-8

Publication history

  • Received April 7, 2016
  • Accepted July 8, 2016
  • First published August 16, 2016.
Online issue publication 
February 15, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.